You are here

Slonomics is a proprietary fully automated genetic-engineering platform that utilizes sets of double stranded DNA triplets in the controlled fabrication of highly diverse combinatorial gene libraries.

The superior combinatorial library enables researchers to increase the success rate of their screening for new and optimized therapeutic antibodies, proteins or industrial enzymes.

Applied to antibodies, Slonomics becomes arYla - a platform providing high quality, ratio-controlled, combinatorial libraries for optimizing antibodies on their functional-, expression- or biophysical properties.